The Society for Neuro-Oncology (SNO)

Nuclear Medicine and Neurooncology (NMN) – Nuklearmedizin und Neuroonkologie Dear colleagues, The NMN symposium aims to provide a highly interactive platform for scientific and educational exchange on the fascinating and clinically highly relevant aspects in research and appli...

🤩 Proud to announce that @neuroonc.bsky.social is officially endorsing the #NMN2026 Symposium and will be represented by Erik Sulman in the meeting faculty! 🧠 🌎 Join us on May 07/08th 2026 in Vienna: www.nmn-society.org.

www.soc-neuro-onc.org
@nathaliealbert.bsky.social @chashaynes.bsky.social

🚨 LAST CALL!

Today is the final day to book your hotel at the discounted rate for #SNOASCO2025!

Stay steps from the action at the Baltimore Marriott Waterfront.

Aug 14–16, 2025

www.soc-neuro-onc.org/SNOASCO2025

Why attend the #SNOASCO2025 CNS Metastases Conference?
🧠 Deep dive into brain metastases across diseases
🌱 Learn from top experts like Helena Yu & Marcela Maus
💬 Engage in multi-sector collaboration
🎯 Focused sessions on biology, treatment, and care

www.soc-neuro-onc.org/SNOASCO2025

Join us for a free informational webinar for medical students, graduate students, residents, fellows or postdocs to learn about exciting opportunities in the multidisciplinary field of neuro-oncology.

Tuesday June 10, 2025, at 6:00 pm ET

Register today! bit.ly/4jsVmX5

🚨 LAST CALL 🚨
Today’s the day! Abstract submissions for WFNOS/SNO 2025 close TONIGHT at 11:59 PM ET.
🏝️ Join us in Honolulu, Nov 19–23.
🌐 Share your science with a global audience.
🔗 Submit now: www.soc-neuro-onc.org/SNO2025

Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy AbstractBackground. Glioblastoma (GBM) carries a poor prognosis, and new therapeutic strategies are necessary to improve outcomes for patients with this di

Read latest from @sjohnliu.bsky.social & Lab in
Neuro-Oncology! "Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy" academic.oup.com/neuro-oncolo... Nature Reviews: www.nature.com/articles/s41... @neuroonc.bsky.social @neurosurgucsf.bsky.social

Have questions about brain tumors, trials, or careers in neuro-oncology?
Ask Dr. Patrick Wen during SNO’s AMAA session!
🗓️ June 18 | 12pm ET
💬 Post questions 24 hours ahead in SNO Central
🔗 Join: snocentral.soc-neuro-onc.org
#SNOAMAA #medicalstudents #btsm #careersinneurooncology

Join us for a free informational webinar for medical students, graduate students, residents, fellows or postdocs to learn about exciting opportunities in the multidisciplinary field of neuro-oncology.

Tuesday June 10, 2025, at 6:00 pm ET

Register today! bit.ly/4jsVmX5

View an important message from the co-chairs of the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day!

Submit your abstract by June 6!

www.soc-neuro-onc.org/SNO2025

⏳ Don’t wait until it’s too late! Early bird registration for #SNOPeds2025 ends TOMORROW!

Join researchers, clinicians, and industry leaders for groundbreaking discussions in pediatric neuro-oncology.

🔗 Register here: www.soc-neuro-onc.org/SNOPeds

Abstract submission deadline is this Monday, March 31 for the 2025 SNO/ASCO CNS Metastases Conference, August 14-16 in Baltimore, Maryland.

Don't miss the opportunity to submit your original research

www.soc-neuro-onc.org/SNOASCO2025?...

Deadline Approaching: Abstract submission for the 2025 SNO/ASCO CNS Metastases Conference

Deadline: Monday, March 31, 2025, 11:59 pm ET

For full information and to submit visit soc-neuro-onc.org/SNOASCO2025

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma - Nature Medicine A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant nivolumab, relatlimab and ipilimumab before maximal resection, with comprehensive immune profiling showing the induction...

This #science exciting! Collaborate, #clincaltrials, nurses, scientists - my co-lead H Rizos🤩. #immunotherapy 4 #GBM #glioblastoma Handed draft trial design+drugs to @jimwhittle.bsky.social @braincancercentre.bsky.social

@sydneyuni.bsky.social @melanomaau.bsky.social
www.nature.com/articles/s41...

Presenting the first broadcast of the SNO Adult Molecular Tumor Board!

Precision Medicine for IDH-mutant Glioma in the IDH-Inhibitor Era: Not all Grade 3 Tumors are Created Equal

Earn Free CME!

April 10, 2025, 1:00-2:00 pm ET

To register: bit.ly/4kzSoln

UCSF neuro-oncologist Susan Chang, MD, FASCO. Photo credit: Patrick Leung.

Congrats to @ucsfhealth.bsky.social neuro-oncologist Susan Chang, MD, FASCO for receiving a 2025 @capilanou.bsky.social Alumni Award of Excellence! 🎉 The Relevance Award recognizes her renowned career as a physician, researcher, and mentor:
www.capilanou.ca/about-capu/g...
@ucsfcancer.bsky.social

🔬✨ Don’t miss the 3rd Annual Highlights of EANO/SNO 2024 webinar! Get expert insights on the top abstracts from #EANO2024 & #SNO2024.

📅 March 7, 2025
⏰ 12:30-1:30 PM ET
📍 Live webinar | FREE to attend!
🔗 Register now: societyforneuro-oncology.tovuti.io/courses/cour...

⏰ Still 2 weeks: Don’t miss the 3rd EANO-SNO Webinar! Our experts will discuss the top abstracts from #EANO2024 (Glasgow) & #SNO2024 (Houston), bringing you the latest updates in #NeuroOncology.
🗓️ March 7, 2025
⏱️ 6:30-7:30pm CET
Register today: eano.eu/eanowebinar/
@neuroonc.bsky.social

Abstract submission for the 2025 SNO/ASCO CNS Metastases Conference is open!

Deadline: Monday, March 31, 2025 at 11:59 pm ET.

Abstracts will be published in an online supplement to the journal, Neuro-Oncology Advances.

For full information visit soc-neuro-onc.org/SNOASCO2025

Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy AbstractBackground. Glioblastoma (GBM) carries a poor prognosis, and new therapeutic strategies are necessary to improve outcomes for patients with this di

Our latest paper on CRISPR-enabled epigenetic editing in glioblastoma is out in @neuroonc.bsky.social! academic.oup.com/neuro-oncolo...

Abstract submission for the 2025 SNO/ASCO CNS Metastases Conference is open!

Deadline: Monday, March 31, 2025 at 11:59 pm ET.

Abstracts will be published in an online supplement to the journal, Neuro-Oncology Advances.

For full information visit soc-neuro-onc.org/SNOASCO2025

Registration is now open! Join leading experts at the 2025 SNO Pediatric Neuro-Oncology Conference for groundbreaking research and collaboration. Secure your spot today! Early bird registration ends April 4th! www.soc-neuro-onc.org/SNOPeds

Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study AbstractBackground. Glioblastoma is the most aggressive adult primary brain cancer, characterized by significant heterogeneity, posing challenges for patie

doi.org/10.1093/neuo...

Submit your research to be a part of the SNO Pediatric Neuro-Oncology Conference! Accepted abstracts will be published in Neuro-Oncology Pediatrics. The deadline to submit is January 10, 2025! For complete information on abstract submission visit www.soc-neuro-onc.org/SNOPeds

UCSF Brain Tumor Center director Mitchel Berger, MD, stands behind the podium delivering his acceptance speech during the Society for Neuro-Oncology's 29th Annual Meeting and Education Day in Houston.

SNO President Daphne Haas-Kogan, MD, introducing this year's winner of the Lifetime Achievement Award. The presentation slide behind her shows a graph charting Dr. Berger's career. Meeting co-chairs Howard Coleman, MD, PhD, Michelle Monje, MD, PhD, Erik Sulman, MD, PhD, and Humsa Venkatesh, PhD, are seated on either side of her.

UCSF Brain Tumor Center director Mitchel Berger, MD, stands on stage and delivers his acceptance speech for the Lifetime Achievement Award from SNO. Meeting co-chairs Howard Coleman, MD, PhD, Michelle Monje, MD, PhD, Erik Sulman, MD, PhD, and Humsa Venkatesh, PhD, are seated on either side of him.

Congratulations to UCSF Brain Tumor Center director Mitchel Berger, MD, on receiving the Lifetime Achievement Award from @neuroonc.bsky.social this past weekend at #SNO2024! This incredible honor recognizes his contributions to the field of neuro-oncology over his career 🎉 @ucsfcancer.bsky.social

Had such an amazing time at #SNO2024 @neuroonc.bsky.social
Wonderful to see updates in CNS tumor treatment, quality of life interventions, and colleagues from around the world!

🥂to another great @neuroonc.bsky.social meeting during #SNO2024! We had a great time with new and old friends and planning projects with upcoming stars! See you again for #SNO2025! In #Hawaii @paosmeade.bsky.social @garciacesara.bsky.social @mariafelicita.bsky.social

Thank you to @neuroonc.bsky.social for another outstanding meeting.

Had a wonderful time @neuroonc.bsky.social annual meeting, speaking on the pharmacodynamic effects of neodajuvant pembrolizumab academic.oup.com/neuro-oncolo...

leaving houston for home after attending a wonderful SNO 2024, Houston with inspiring murals. time to leap to the future!